Stockchase Opinions

Stockchase InsightsCoreWeaveCRWVBUY ON WEAKNESSSep 05, 2025

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

CRWV is in a nearly 50% 3-month drawdown and the EV/Sales valuation has reverted to 7X. Revenues are expected to double in 2026. After this drawdown, we think it is starting to look better here and we would be ok with picking away at the name at this stage with the caveat that it remains higher risk and volatile.
Unlock Premium - Try 5i Free  

$89.09

Stock price when the opinion was issued

$106.94

As of May 28, 2026. Market Open.

Technology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WEAK BUY
CRWV vs. NBIS

Think of them as intelligence farms and data centres. You can get a lot more $$ from renting the GPUs than people had thought, and the assets don't depreciate as quickly as feared. There's just so much demand.

Was contentious when it came out, as it was a race between its interest expense on debt versus revenue generated from renting out compute. 

Likes both, prefers NBIS. A bit more responsible with its balance sheet.

DON'T BUY

A play on data centres. What does data centre growth look like? It was everything to everybody. Now growth is in question as people wonder where's the $$ coming from to build them? His own heart tells him that growth won't be what it was thought. Maine just voted to impose a ban on data centres.

Stock's tired. See his Top Picks.

DON'T BUY

The $1.4 billion in loans that OWL sold in the past several days were sold at par value; at least these loans were not impaired. But what does the rest of their portfolio look like? We need time and some financing getting completed.

HOLD
NBIS vs. CRWV

She prefers the bitcoin miners, as their business model is a bit less risky. Both of these names look pretty attractive here, as H100 and H200 chip prices are still going up. So there's a bit more upside in the short term. Over the cycle, they don't have demand locked in. They're investing a lot of capex, and though demand is there today, the future is uncertain.

CRWV has the backing of NVDA, so it may be a bit better on risk/reward. Both have similar exposure.

DON'T BUY

Up 93% since last year's IPO, but peaked early and has tumbled 59% from that high.

BUY

They use debt to build data centres, but he's not worried, because he trusts the CEO--there's a lot of demand for the centres.

WATCH

A lot going for it, as it's involved in the networking space. Massive company at almost $50B, considering it IPO'd only 6 months ago. His price target is $123. He'd pick it up if it got down to low-mid $80s.

COMMENT

Is +134% since its March IPO. Likes the fundamental business but was too high during its June peak. The lock-up on insider selling has expired, so shares have fallen below $100. Still, has performed well.

DON'T BUY

It will keep falling. Only then will the stock tell you what to do. Till then, look elsewhere.

DON'T BUY

One of the most contentious stocks right now. Drastic undersupply of GPUs to power systems, but how long will this last? Another question is how proprietary, really, is what CRWV's doing? Concerning debt profile, burning cash. Follow the free cashflow.

BUY ON WEAKNESS

Likes it, but there are too many shorts in it, so this needs to come down before you look at it.

BUY ON WEAKNESS

It IPO'd poorly in March, then took off. Today, it got hit after announcing it was buying Core Scientific for $9 billion, already a partner with CRWV. Share fell 3.33% (Core -17.61%)

PARTIAL SELL

He recommended it when they IPO'd and it's run up 300%. Sell half your holding.

SELL

NVDA owns 7% of this and the hyperscalers are interested in this. It's still losing money and trades at premium multiples. But they can pivot in the marketplace with both hardware and software in their data centres. They cater to smaller/medium-size companies. But they carry a lot of debt, but that's needed for the capex. Rapid tech obsolence is also a caveat. This could fall below $100.